Clinical pharmacy services, pharmacist staffing, and drug costs in United States hospitals

被引:58
作者
Bond, CA
Raehl, CL
Franke, T
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Pharm Practice, Sch Pharm, Amarillo, TX 79106 USA
[2] Univ Calif Los Angeles, Sch Publ Policy & Social Res, Dept Biostat & Biometr, Los Angeles, CA USA
来源
PHARMACOTHERAPY | 1999年 / 19卷 / 12期
关键词
D O I
10.1592/phco.19.18.1354.30893
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We evaluated direct relationships and associations among clinical pharmacy services, pharmacist staffing, and drug costs in United States hospitals, A database was constructed from the 1992 American Hospital Association's Abridged Guide to the Health Care Field and the 1992 National Clinical Pharmacy Services database. Multiple regression analysis, controlling for severity of illness, was employed to determine the associations. The study population consisted of 934 hospitals. Four clinical pharmacy services were associated with lower drug costs: in-service education, $77,879.19 +/- $56,203.42 (a total of $48,518,935.37 for the 623 hospitals offering this service, p=0.016); drug information,$430,579.84 +/- $299,232.76 ($90,852,346.24 for the 211 hospitals offering this service, p=0.015); drug protocol management, $137,333.67 +/- $98,617.83 ($45,045,443.76 for the 328 hospitals offering this service, p=0.049); and admission drug histories, $213,388.21 +/- $201,537.85 ($5,548,093.46 for the 26 hospitals offering this service, p= 0.011). As staffing increased for hospital pharmacy administrators (p<0.0001), dispensing pharmacists (p<0.0001), and pharmacy technicians (p<0.0001), drug costs increased. As staffing increased for clinical pharmacists, drug costs decreased (p=0.018). The results of this study show that increased staff levels of clinical pharmacists and some clinical pharmacy services are associated with reduced hospital drug costs.
引用
收藏
页码:1354 / 1362
页数:9
相关论文
共 53 条
  • [1] USE OF CLINICAL PHARMACISTS TO REDUCE CEFAMANDOLE, CEFOXITIN, AND TICARCILLIN COSTS
    ABRAMOWITZ, PW
    NOLD, EG
    HATFIELD, SM
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1982, 39 (07): : 1176 - 1180
  • [2] *AM COLL CLIN PHAR, 1999, WORLD C CLIN PHARM P
  • [3] *AM COLL CLIN PHAR, 1997, ACCP REP, V16, pS1
  • [4] *AM HOSP ASS, 1992, ABR GUID HLTH CAR FI
  • [5] *AM HOSP ASS, 1993, HOSP STAT
  • [6] IMPROVING DRUG-THERAPY DECISIONS THROUGH EDUCATIONAL OUTREACH - A RANDOMIZED CONTROLLED TRIAL OF ACADEMICALLY BASED DETAILING
    AVORN, J
    SOUMERAI, SB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (24) : 1457 - 1463
  • [7] BARKER KN, 1986, HDB I PHARM PRACTICE, P325
  • [8] INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION
    BATES, DW
    CULLEN, DJ
    LAIRD, N
    PETERSEN, LA
    SMALL, SD
    SERVI, D
    LAFFEL, G
    SWEITZER, BJ
    SHEA, BF
    HALLISEY, R
    VANDERVLIET, M
    NEMESKAL, R
    LEAPE, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01): : 29 - 34
  • [9] EFFECT OF PHARMACISTS ON HEALTH-CARE OUTCOMES IN HOSPITALIZED-PATIENTS
    BJORNSON, DC
    HINER, WO
    POTYK, RP
    NELSON, BA
    LOMBARDO, FA
    MORTON, TA
    LARSON, LV
    MARTIN, BP
    SIKORA, RG
    CAMMARATA, FA
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (09): : 1875 - 1884
  • [10] BLACK BL, 1986, RESOURCE BOOK PROGR